Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Multi Bintang Indonesia Tbk. (MLBI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Multi Bintang Indonesia Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Multi Bintang Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Bintang Indonesia Tbk. trades at Rp6,325 (market cap 13.33T, 51.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 79.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 51.1K). Which is the better fit depends on your goals.

MLBIOBAT
Market Cap
13.33T167.37B
Volume
51.1K96.7K
Lot
511967
Turnover
322.91M23.82M
Average Price
6,319.08246.34
Value
322.91M23.82M
Indicative Equilibrium Price
248
Indicative Equilibrium Volume
41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MLBI
View details
OBAT
View details

About Multi Bintang Indonesia Tbk.

PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).

Read more on MLBI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT